Medtech innovator accelerates manufacture of ground-breaking cancer treatment

Posted on 11 Jul 2023 by The Manufacturer

A medtech innovator has accelerated its R&D and manufacture of its ground-breaking cancer treatment, after funding from Innovate UK’s Analysis for Innovators (A4I) programme.

LightOx, based in Newcastle, has developed a UK-first early-stage mouth cancer treatment using light-activated chemotherapy. The treatment involves a gel being applied to the affected area and the drug activated with light. It is undergoing preclinical testing, is quick, simple and non-invasive with fewer side effects than surgery and significantly improves the overall patient experience.…

You’ve reached your free article limit for this month. Subscribe for free to continue reading and unlock full access.